CUV 1.61% $14.68 clinuvel pharmaceuticals limited

deciphering the ceo letter, good and bad, page-7

  1. 594 Posts.
    lightbulb Created with Sketch. 281
    you're an interesting guy.

    everyone has to make their first post at some point.

    I am new to the site and was enjoying reading your previous comments. As the Swiss have recently approved afamelanotide and CUV029 and CUV030 were overwhelmingly positive I was drawn to the relevance of your comment:

    "However, the share price will not do much until they 1) release unequivocal good EPP results and/ or 2) there is some surprise such as another European country (such as Switzerland, the UK, Germany, etc.) follows suit with the Italians and says"

    I did begin my post with the words no disrespect intended and apologise if if you feel that I have been. I am aware that it is not yourself that controls the sp.

    My prediction for you is that PW will do everything he can to prevent a dilutive capital raising at anywhere near current sp. i expect some sort of JV announcement with big pharma in the upcoming months
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.